PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Diapharm Starts GMP Audit Service for Active Pharmaceutical Ingredients - Pharma service provider Diapharm is now offering accredited shared third-party audits for active pharmaceutical ingredients (APIs)
Diapharm Starts GMP Audit Service for Active Pharmaceutical Ingredients

 

NewswireToday - /newswire/ - Muenster, North Rhine-Westfalia, Germany, 2008/09/11 - Pharma service provider Diapharm is now offering accredited shared third-party audits for active pharmaceutical ingredients (APIs).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Pharma service provider Diapharm is now offering accredited shared third-party audits for active pharmaceutical ingredients (APIs). In a shared audit several medicinal product manufacturers jointly commission the check of production conditions for a starting material or API such as ibuprofen or naproxen. The resulting audit report serves to prove whether the rules of good manufacturing practice (GMP) are followed in the manufacture of the ingredient. This proof of GMP compliance is mandatory for European manufacturers of medicinal products. “Accredited third-party audits offer additional security, since they are also recognized internationally by the authorities”, explains Dorothee Klöpf of Diapharm, responsible for the GMP audit service. For these checks Diapharm collaborates with the independent, accredited blue inspection body GmbH. Upon request, blue also undertakes the management of deficiencies.

About 80 percent of the starting materials and APIs used in the production process of medicinal products in Europe come from third countries such as India or China. With the shared audit concept, Diapharm spreads the cost of auditing the APIs among several parties, interested medicinal product manufacturers in Europe who jointly commission an audit of an API manufacturer.

For the 4th quarter of 2008 Diapharm (diapharm.com) is coordinating shared-audit trips to China and India. Audits are to be made of, among others, manufacturers of acetylsalicylic acid, atorvastatin, ciprofloxacin, caffeine, donepezil, hydrocortisone, ibuprofen, levofloxacin, lovastatin, metamizole, naproxen, naratriptan, paracetamol, pravastatin, propyphenazone, rizatriptan, rosiglitazone, rosuvastatin, simvastatin, sotalol, sumatriptan, theophylline, trimethoprim and zolmitriptan. Diapharm also supplies ready-made GMP audit reports for a steadily increasing number of starting materials and APIs.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Diapharm Starts GMP Audit Service for Active Pharmaceutical Ingredients

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Nicole Sibbing - Co-Operate.net 
+49(0)251 60935-11 karin.mueller[.]diapharm.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Werbeagentur & PR-Agentur co-operate securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Werbeagentur & PR-Agentur co-operate / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)